Skip to content
Nikang Therapeutics
Nikang Therapeutics
  • About Us
  • Science & Pipeline
  • News
  • Careers
  • Home
  • About us
  • Science & Pipeline
  • News
  • Careers

NiKang Therapeutics® to Present Preliminary Results of Phase 1/2 Clinical Trial of NKT2152 in Patients with Previously Treated Advanced Clear Cell Renal Cell Carcinoma at ESMO 2024 Congress

See the press release on Business Wire

Contact Us

Please use this form to contact the NiKang Therapeutics team for all inquiries.

Nikang Therapeutics

200 Powder Mill Road
Bldg E500
Wilmington, DE 19803

P:

302-415-5127
info@nikangtx.com
www.nikangtx.com

© 2023 NiKang Therapeutics, Inc. All Rights Reserved.

Privacy Policy | Terms & Conditions

Go to Top